Genzyme Corporation (Nasdaq: GENZ) announced today that the U.S. Food and Drug Administration has granted marketing approval for Mozobil (plerixafor ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE